Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

The Hospital at Home: A New Approach to Patient Care – By Stuart Long, CEO of InfoBionic

By Stuart Long, CEO of InfoBionic

It became clear in March of 2020 that because of the Covid-19 pandemic, hospitals were at tremendous risk of becoming overwhelmed with sick patients. Bed capacity became a primary concern as more people needed extended hospitalization that required intensive care.

In response, the Centers for Medicare and Medicaid Services (CMS) altered a number of federal regulations governing healthcare organizations. The new set of rules, known collectively as the Hospitals without Walls program(1), was designed to help healthcare organizations continue to deliver high-quality patient care outside of the hospital itself.

Efforts to combat the pandemic routinely included remote patient monitoring (RPM) and telehealth technologies. In November, CMS introduced its Acute Hospital Care At Home program, which expanded on the initial efforts of Hospitals Without Walls by supporting various models of at-home hospital care.(2)

Expanded services

In the wake of this regulatory expansion, healthcare organizations began offering additional services inside the patient’s home. Acute Hospital Care at Home, now generally known as the Hospital in the Home, began to offer treatment for more than 60 medical conditions identified by CMS as capable of being treated safely and effectively at home; among them were asthma, congestive heart failure, pneumonia, and chronic obstructive pulmonary disease (COPD).(2)

After an initial face-to face-evaluation by a physician, qualifying patients were allowed to receive care remotely. Registered nurses could evaluate each patient at least once a day, using remotely gathered information to help make treatment decisions.

What began as an emergency measure has since become mainstream, as more and more healthcare providers adopt telehealth and remote monitoring as essential components of patient care. It has been estimated that as many as 30 million Americans will use some type of remote patient monitoring tool by 2024.(3)

Application to cardiology

Remote monitoring technologies and telehealth have been adopted in some medical subspecialties more than others. Cardiologists, for example, were some of the earliest to use these technologies to keep tabs on patients outside hospital walls,(3) and are still among the heaviest users of the capability.

One reason for this is simple need. Chronic diseases like heart disease are the leading causes of death and disability in the United States, costing the country an estimated $3.8 trillion in annual healthcare costs.(4) According to the American Heart Association, it costs 3.5 times more to treat a chronic condition compared to other medical concerns.

Today, implantable devices, biosensors, blood pressure cuffs, and pulse oximeters are all part of RPM technology regularly used by cardiologists to check in on patients located outside the hospital setting.

Many are small and unobtrusive enough to be worn by patients all day, every day. They automatically measure and transmit data at a distance, usually using wireless technology. Providers access the patient’s complete medical record, making treatment recommendations as the patient’s condition changes in real time.

Better care?

RPM devices, in short, allow physicians to capture a holistic view of a patient’s health over time, increase their understanding of the patient’s compliance with treatment recommendations, and enable timely interventions before costly care episodes.

The American Heart Association, for example, estimates that more than 42% of all American adults will be diagnosed with hypertension by 2035, an increase of 27 million people. Initial research shows that RPM reduces both systolic and diastolic blood pressure significantly compared to typical medical care and self-monitoring alone. Other research suggests that RPM’s positive impact on systolic blood pressure increases with long-term use and multiple behavior change techniques.(5)

Remote monitoring also provides potential benefits for the estimated 2.7 to 6.1 million people in the United States who live with atrial fibrillation (AFib), a dangerous and potentially deadly type of cardiac arrythmia. AFib is associated with increased risk for other adverse events, such as heart failure, stroke, increased number of hospitalizations, and death. Early indications show that RPM may help improve outcomes for many through early detection and treatment of AFib, in turn decreasing all-cause mortality rates and hospitalizations.(5)

The Future of Remote Patient Monitoring

It’s likely that the future of healthcare itself will be a hybrid model of care combining virtual, noninvasive monitoring with physician consultations and traditional physical examinations. According to McKinsey & Company, consumer use of telehealth services — including remote patient monitoring — has risen from 11% in 2019 to 46% today.

The global remote patient monitoring market is projected to reach $175.2 Billion by 2027 from $53.6 Billion in 2022, at a CAGR of 26.7% during the forecast period.(6) And cardiology, according to the projection, isn’t the only subspecialty where remote patient monitoring can improve outcomes. Monitoring services may eventually include conditions like diabetes and obesity. There is even some speculation that RPM could be used to help diagnose and manage problems like obstructive sleep apnea.

All this is possible because of evolving technology. Patients already use smartphone apps to share information from remote monitoring devices directly to their providers. Sophisticated cloud-sharing platforms are also proving essential to the success of this hybrid model of healthcare, as many allow the integration of numerous types of RPM devices for the same patient. These same platforms also allow healthcare providers to easily view and manage patient data.

Now, many providers are leveraging mobile-enabled remote patient monitoring, which may be more cost effective and efficient compared to other monitoring technologies. These devices use notifications that prompt users to enter data, providing almost instant clinical and financial value to large and small practices alike.(7)

Possibilities on the horizon

Current generations of remote patient monitoring technology cannot monitor all vitals—oxygen level, ECG, blood pressure, blood glucose, etc.—at the same time and/or in the same device. However, biotech companies are working to develop a kind of “tricorder” technology, similar to that seen in “Star Trek”. It is anticipated that this kind of innovative technology will become more precise, more accepted, and simply a reality—hopefully, in the not-too-distant future.

Healthcare delivery in the virtual world is on the rise, and it will only continue to expand as more patients and providers turn to remote monitoring or telehealth options. These essential augmentations to the existing healthcare landscape are already helping doctors manage a variety of chronic health conditions, like heart disease. And these technologies bridge the care gap that many experience because of socioeconomic, geographical, or environmental difficulties.

The Hospital in the Home model of healthcare gives patients more freedom of choice and autonomy over their own health and treatment decisions. Remote monitoring technologies also help keep patients safe, even if they aren’t at risk for COVID-19. These technologies represent a fundamental change in how people access healthcare, analyze health data, and make decisions that improve patient outcomes. It truly is a win-win situation for everyone.

About Stuart Long

Stuart Long was appointed CEO of InfoBionic in March 2017. With more than 20 years of experience in the medical device market, Mr. Long brings a great deal of expertise in achieving rapid commercial growth. Prior to joining InfoBionic, he was CEO at Monarch Medical Systems, LLC, a Charlotte-based, artificial intelligence clinical decision support software provider for insulin dosing calculations, where he oversaw the organizational restructuring of the company.


  1. “Fact Sheet Additional Background:Sweeping Regulatory Changes to Help U.S. Healthcare System Address COVID-19 Patient Surge.” CMS, 30 Mar. 2020,
  2. “Press Release CMS Announces Comprehensive Strategy to Enhance Hospital Capacity Amid COVID-19 Surge.” CMS, 25 Nov. 2020,
  3. Tashnek, Daniel, JD. “How Remote Patient Monitoring Is Changing the Practice of Cardiology.” Practical Cardiology, 6 Nov. 2020,
  4. Dolan, Shelagh. “The Technology, Devices, and Benefits of Remote Patient Monitoring in the Healthcare Industry.” Business Insider, Business Insider, 10 Mar. 2021,
  5. “Chronic Diseases in America.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 12 Jan. 2021,
  6. “Remote Patient Monitoring Market by Product, End user – Global Forecast to 2027”, ReportLinker, March 2022,
  7. Dillard, Robert. “What Is the Future of Remote Patient Monitoring (RPM)?” Docwire News, 28 Feb. 2020,
Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Experts Views and Opinions

A Platform Approach: Expanding a Molecular Diagnostic Device Beyond Human Applications | By Shaun Holt, CEO, Alveo Technologies

Holt writes, "Avian flu is a global crisis, and not just for the poultry industry. There are serious potential implications for human health as well. But, let’s start with agriculture. Some strains of avian flu can be highly pathogenic. Once a single bird shows symptoms the clock starts ticking — it’s not unusual for an entire flock of tens of thousands of birds to die within two to three days."

The Hollywood Writers’ Strike and Ethical AI | By Ed Watal, Founder & Principal — Intellibus

Watal writes, "Less than 12 months ago, with the debut of AI-powered ChatGPT, the true power of AI hit the mainstream. Since then, it has established an unshakeable belief in everyone’s minds that artificial intelligence is here to stay and will forever alter a number of industries." What do you think? Read on.

Viraj Gandhi On Automation and Technology – to Drive Progress in Pharmaceutical Manufacturing

This article takes a closer look at the key benefits of automation and technology in pharmaceutical manufacturing and how Medivant Healthcare harnesses these solutions to drive progress across our production facilities. Read what Viraj Gandhi has to say.

Limb Loss and Preservation Registry (LLPR) Transforms Care Through Data and Insights | By Shawn Murphy, Vice President, Thought Leadership & Innovation Foundation...

Shawn Murphy writes, "The Limb Loss and Preservation Registry (LLPR) represents a pivotal development in patient care. It stands as the first collaborative database that unites hospital and health systems, provider organizations such as Accountable Care Organizations (ACOs), Integrated Delivery Networks (IDNs) and orthotic/prosthetic (O&P) practices, focusing on both upper and lower extremity acquired and congenital limb differences, as well as limb preservation populations. This collective effort has the potential to drive substantial advancements in patient outcomes, treatment effectiveness and care quality." Read to learn more.

It Takes an Ecosystem – Bringing Stakeholders Together is a Critical 1st Step to Solving Problems In Healthcare | By Andrew Cleeland, CEO, Fogarty...

Andrew Cleeland writes, "Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value proposition. My mentor, Dr. Thomas Fogarty, once said, “An idea, by itself, has no importance whatsoever; it is the implementation of that idea and its acceptance by others that brings benefit to our patients.” Read on.

By using this website you agree to accept Medical Device News Magazine Privacy Policy